Archives: Questions And Answers
Hi team,
I see that you have a limit of 20 stocks in the Growth portfolio but I can’t see any mention of how many are allowed in the income or emerging portfolios. Are they allowed more stocks? Also whilst many say a 20 stock portfolio seems to be reasonably standard, would you consider lifting this number if funds grew to a level where you would feel uncomfortable having large amounts of cash in each holding?
Thanks for your continuing good work which is always appreciated. You have recently been mentioning EOFY tax loss selling quite often, but I don’t see the benefit of this activity and why it would occur. Losses at 30 June will be recognised when placed in your Profit and Loss Account at “the lower of original cost or market value”, which is permitted by the ATO, while any stocks sold in the lead up to 30 June will be placed under “Sales” but will be thus be absent from “Closing Stock” which thus balances out the figures at the Gross Profit line of your year end Profit and Loss Account. Thus there seems no benefit at all to pre 30 June tax loss selling, so why would it be used as a tactic?
Hi James & team.
Hi James and team,
I am interested in your current views on Calix (CXL). I note they raised capital about 18 months ago at a much higher level to the current share price. The share price has been in a downward spiral since then. They appear to be spending most of their money on research and development.
Three questions. Do you believe there is a risk of another capital raise in the near term; are they likely to start making money in the near future; and would you be a buyer at these levels if you didn’t already own them in the Emerging Companies Portflio?
Thank you
Chris G.
Hi again,
How and when are dividends distributed in Market Matters portfolios.
